Muhammad Omar, Joel Tjarks, Kashif Abbas Shaikh, Kalyan Chakravarthy Potu, Uma M Mothapothula and Maheedhar Gedela. An Unusual Site of Metastasis of Malignant Mixed Müllerian Tumor of the Uterus.
. 2016; 4(2):41-43. doi: 10.12691/AJMCR-4-2-2
Malignant mixed müLlerian tumor, metastasis, malignancy, uterus
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Robinson-Bennett, B., R.Z. Belch, and A.C. Han, Loss of p16 in recurrent malignant mixed mullerian tumors of the uterus. Int J Gynecol Cancer, 2006. 16(3): p. 1354-7. |
|
[2] | Nguyen, C.P., et al., Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus. Gynecol Oncol, 2000. 79(3): p. 499-503. |
|
[3] | Bostwick, D.G. and L. Cheng, Urologic surgical pathology. Third edition. ed. 2014, Philadelphia, PA: Elsevier/Saunders. p. |
|
[4] | Gadducci, A., et al., The management of patients with uterinesarcoma: a debated clinical challenge. Crit Rev Oncol Hematol, 2008. 65(2): p. 129-42. |
|
[5] | Lopez-Garcia, M.A. and J. Palacios, Pathologic and molecular features of uterine carcinosarcomas. Semin Diagn Pathol, 2010. 27(4): p. 274-86. |
|
[6] | Kernochan, L.E. and R.L. Garcia, Carcinosarcomas (malignant mixed Mullerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics. J Natl Compr Canc Netw, 2009. 7(5): p. 550-6; quiz 557. |
|
[7] | Iwasa, Y., et al., Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients. Cancer, 1998. 82(3): p. 512-9. |
|
[8] | Callister, M., et al., Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys, 2004. 58(3): p. 786-96. |
|
[9] | Ali, S. and M. Wells, Mixed Mullerian tumors of the uterine corpus: a review. Int J Gynecol Cancer, 1993. 3(1): p. 1-11. |
|
[10] | Lotocki, R., et al., Mixed Mullerian tumors of the uterus: clinical and pathologic correlations. Int J Gynaecol Obstet, 1982. 20(3): p. 237-43. |
|
[11] | Ulbricht, L.J., et al., Intracardiac metastasis of a Malignant Mixed Mullerian tumor (MMMT): progressive dyspnoea due to obstruction of the left atrium and the left ventricle without left ventricular dysfunction or primary lung disease. Wien Med Wochenschr, 2009. 159(13-14): p. 355-8. |
|
[12] | N'Kanza, A.L., et al., Central nervous system involvement from malignant mixed Mullerian tumor (MMMT) of the uterus. Arch Gynecol Obstet, 2005. 273(1): p. 63-8. |
|
[13] | Plaza, J.A., et al., Metastases to soft tissue: a review of 118 cases over a 30-year period. Cancer, 2008. 112(1): p. 193-203. |
|
[14] | Horn, L.C., M. Dallacker, and K. Bilek, [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors]. Pathologe, 2009. 30(4): p. 292-301. |
|
[15] | Herring, C.L., Jr., J.M. Harrelson, and S.P. Scully, Metastatic carcinoma to skeletal muscle. A report of 15 patients. Clin Orthop Relat Res, 1998(355): p. 272-81. |
|
[16] | Komatsu, S., et al., [A case of malignant psoas syndrome diagnosed while treating sciatica]. Masui, 2013. 62(7): p. 863-6. |
|
[17] | Gharaibeh, K.A., A. Lopez-Ruiz, and T. Yousuf, Psoas muscle infiltration masquerading distant adenocarcinoma. Case Rep Gastrointest Med, 2014. 2014: p. 986453. |
|
[18] | Kenny, J.B., et al., Malignant involvement of the iliopsoas muscle: CT appearances. Eur J Radiol, 1990. 10(3): p. 183-7. |
|
[19] | Williams, J.B., et al., MR imaging of skeletal muscle metastases. AJR Am J Roentgenol, 1997. 168(2): p. 555-7. |
|
[20] | Avery, G.R., Case report: Metastatic adenocarcinoma masquerading as a psoas abscess. Clinical Radiology, 1988. 39(3): p. 319-320. |
|
[21] | Lenchik, L., D.J. Dovgan, and R. Kier, CT of the iliopsoas compartment: value in differentiating tumor, abscess, and hematoma. American Journal of Roentgenology, 1994. 162(1): p. 83-86. |
|
[22] | Singh, R., Review literature on uterine carcinosarcoma. J Cancer Res Ther, 2014. 10(3): p. 461-8. |
|
[23] | Raspollini, M.R., et al., COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? Gynecol Oncol, 2005. 96(1): p. 159-67. |
|